Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Dibah42on Aug 31, 2020 11:03am
117 Views
Post# 31479202

A statistician in today's Guardian on Hahn & 35%

A statistician in today's Guardian on Hahn & 35%

https://www.theguardian.com/commentisfree/2020/aug/31/politicians-covid-19-statistics-statisticians


Numbers may not measure what you think they may be measuring, but they are rarely completely wrong. That’s why the statistical community let out a collective gasp last Sunday when Stephen Hahn, the commissioner of the US Food and Drug Administration, told a press conference that treatment with convalescent plasma would mean that of “100 people who were sick with Covid-19, 35 would have been saved”. If true, this would be one of the most remarkable medical discoveries in history, saving one life for every three people treated. But it is completely false. In fact 8.9% of the treated group died, compared with 13.7% of a comparison group, a 35% relative difference. The absolute difference was 5%, so if we believed the figures, in fact 20 people had to be treated to save one life. But we should not even believe those numbers, being based on selected patients receiving the treatment, and not comparing like with like in a proper randomised design.

This is possibly the most statistically dim-witted utterance I have witnessed from any authority during this crisis, and he’s up against some pretty stiff competition, not least from the president flanking him at the press conference.

<< Previous
Bullboard Posts
Next >>